Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven N Goodman

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
JAMA Network Open|May 26, 2021
Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic ReviewTahmina Nasserie, Michael Hittle, Steven N Goodman
Annals of Internal Medicine|November 18, 2020
The Role of Masks in Mitigating the SARS-CoV-2 Pandemic: Another Piece of the PuzzleChristine Laine, Steven N Goodman, Eliseo Guallar
Journal of the American College of Cardiology|February 5, 2011
Pharmacogenetic testing for warfarin dosing still awaits validationFrank Lefevre, Steven N Goodman, Margaret A Piper
JAMA|June 1, 2002
How statistical expertise is used in medical researchDouglas G Altman, Steven N Goodman, Sara Schroter
Clinical Trials (London, England)|October 3, 2015
An interview with David Sackett, 2014-2015David Sackett, R Brian Haynes, Steven N Goodman
JAMA|July 26, 2019
Harms From Uninformative Clinical TrialsDeborah A Zarin, Steven N Goodman, Jonathan Kimmelman
Clinical Trials (London, England)|June 9, 2016
Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent researchHao Wang, Gary L Rosner, Steven N Goodman
The New England Journal of Medicine|June 7, 2018
Clinical Trial Participants' Views of the Risks and Benefits of Data SharingMichelle M Mello, Van Lieou, Steven N Goodman
Annals of Internal Medicine|December 4, 2018
Machine Learning, Health Disparities, and Causal ReasoningSteven N Goodman, Sharad Goel, Mark R Cullen
JAMA|May 23, 2013
Advances in regulatory science at the Food and Drug AdministrationBruce M Psaty, Steven N Goodman, Alasdair Breckenridge
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
JAMA Network Open|May 26, 2021
Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic ReviewTahmina Nasserie, Michael Hittle, Steven N Goodman
Annals of Internal Medicine|November 18, 2020
The Role of Masks in Mitigating the SARS-CoV-2 Pandemic: Another Piece of the PuzzleChristine Laine, Steven N Goodman, Eliseo Guallar
Journal of the American College of Cardiology|February 5, 2011
Pharmacogenetic testing for warfarin dosing still awaits validationFrank Lefevre, Steven N Goodman, Margaret A Piper
JAMA|June 1, 2002
How statistical expertise is used in medical researchDouglas G Altman, Steven N Goodman, Sara Schroter
Clinical Trials (London, England)|October 3, 2015
An interview with David Sackett, 2014-2015David Sackett, R Brian Haynes, Steven N Goodman
JAMA|July 26, 2019
Harms From Uninformative Clinical TrialsDeborah A Zarin, Steven N Goodman, Jonathan Kimmelman
Clinical Trials (London, England)|June 9, 2016
Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent researchHao Wang, Gary L Rosner, Steven N Goodman
The New England Journal of Medicine|June 7, 2018
Clinical Trial Participants' Views of the Risks and Benefits of Data SharingMichelle M Mello, Van Lieou, Steven N Goodman
Annals of Internal Medicine|December 4, 2018
Machine Learning, Health Disparities, and Causal ReasoningSteven N Goodman, Sharad Goel, Mark R Cullen
JAMA|May 23, 2013
Advances in regulatory science at the Food and Drug AdministrationBruce M Psaty, Steven N Goodman, Alasdair Breckenridge
Pageof 15